| Record ID | ia:psychiatricdrugs0000heal_i6l1_6thed |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/psychiatricdrugs0000heal_i6l1_6thed/psychiatricdrugs0000heal_i6l1_6thed_marc.xml |
| Download MARC binary | https://www.archive.org/download/psychiatricdrugs0000heal_i6l1_6thed/psychiatricdrugs0000heal_i6l1_6thed_meta.mrc |
LEADER: 03860cam 2200709 a 4500
001 ocn947815626
003 OCoLC
005 20220802214309.0
008 160426s2016 stka bf 001 0 eng
007 ta
010 $a 2016302490
040 $aNLM$beng$cNLM$dEQF$dNZTHL$dLTSCA$dBKL$dOCLCF$dOCLCO$dDLC$dSHS$dOCLCO$dCUY$dR2A$dLIP$dSFR$dUKWOH$dOCLCA$dCLE$dOCL$dOCLCO$dOCLCQ$dAU@$dOCLCQ$dNLM$dOCLCO$dOCLCA$dOCLCQ$dOCLCO$dUKUSF$dOCLCO
016 7 $a101685350$2DNLM
019 $a946990717$a948681783$a987027689$a988717362$a1109534699$a1154102719$a1154984947$a1249789171
020 $a9780702045080
020 $a070204508X
035 $a(OCoLC)947815626$z(OCoLC)946990717$z(OCoLC)948681783$z(OCoLC)987027689$z(OCoLC)988717362$z(OCoLC)1109534699$z(OCoLC)1154102719$z(OCoLC)1154984947$z(OCoLC)1249789171
037 $bElsevier Science Health Science, Attn Customer Service 11830 Westline Industrial Dr, Saint Louis, MO, USA, 63146$nSAN 200-2280
042 $anlmcopyc
050 4 $aRM315$b.H435 2016
060 00 $a2016 F-034
060 10 $aQV 39
072 7 $aHEA$2eflch
072 7 $aHEA$2ukslc
082 04 $a615/.788$223
100 1 $aHealy, David,$d1954-
245 10 $aPsychiatric drugs explained /$cDavid Healy.
250 $a6th ed.
260 $aEdinburgh ;$aNew York :$bElsevier,$c[2016]
300 $axiv, 339 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aAntipsychotics -- Antipsychotic side effects and their management -- Antidepressants -- Side effects of antidepressants -- Management of acute bipolar disorder -- Mood-stabilisers -- Stimulants and drugs for children -- Anxiety disorders -- Benzodiazepine anxiolytics -- Anxiolysis and the serotonin system -- Beta-blockers and anxiety -- Sleep disorders and insomnia -- Non-pharmacological management of insomnia -- Hypnotics -- Sedatives -- Cognitive enhancement and the dementias -- Cognitive enhancement and neuroprotection -- The range of sexual difficulties -- Effects of drugs on aspects of sexual functioning -- Dependence and withdrawal -- Dependence and craving -- Dependence and protracted withdrawal -- Consent -- Pharmacological abuse -- The ethical industry -- Evidence-biased care -- Marketing and risk -- From health care to pharmageddon.
520 8 $aThis text provides drug names in generic as well as both UK and US tradenames. In addition to a comprehensive review of drug treatment organised by condition, the text also addresses important issues for professionals and their clients concerning consent, liability, and the management of side effects and withdrawal.
650 0 $aPsychotropic drugs.
650 0 $aPsychopharmacology.
650 0 $aMental illness$xChemotherapy.
650 12 $aMental Disorders$xdrug therapy
650 22 $aPsychotropic Drugs$xtherapeutic use
650 2 $aPsychotropic Drugs
650 2 $aPsychopharmacology
650 6 $aPsychotropes.
650 6 $aPsychopharmacologie.
650 6 $aMaladies mentales$xChimiothérapie.
650 7 $aHealth and Fitness.$2eflch
650 7 $aMental illness$xChemotherapy.$2fast$0(OCoLC)fst01016553
650 7 $aPsychopharmacology.$2fast$0(OCoLC)fst01081659
650 7 $aPsychotropic drugs.$2fast$0(OCoLC)fst01081826
650 7 $aHealth and Wellbeing.$2ukslc
655 2 $aHandbook
655 7 $amanuals (instructional materials)$2aat
655 7 $ahandbooks.$2aat
655 7 $aHandbooks and manuals.$2fast$0(OCoLC)fst01423877
655 7 $aHandbooks and manuals.$2lcgft
655 7 $aGuides et manuels.$2rvmgf
029 0 $aNLM$b101685350
029 1 $aAU@$b000060913190
029 1 $aNZ1$b16314275
994 $aZ0$bIME
948 $hNO HOLDINGS IN IME - 104 OTHER HOLDINGS